HK1221666A1 - 氨基吡啶用於治疗与某些中风类型相关的视觉障碍的方法 - Google Patents

氨基吡啶用於治疗与某些中风类型相关的视觉障碍的方法 Download PDF

Info

Publication number
HK1221666A1
HK1221666A1 HK16109985.0A HK16109985A HK1221666A1 HK 1221666 A1 HK1221666 A1 HK 1221666A1 HK 16109985 A HK16109985 A HK 16109985A HK 1221666 A1 HK1221666 A1 HK 1221666A1
Authority
HK
Hong Kong
Prior art keywords
stroke
aminopyridines
methods
certain types
impairments associated
Prior art date
Application number
HK16109985.0A
Other languages
English (en)
Chinese (zh)
Inventor
Andrew R. Blight
Anthony O. Caggiano
Tom J. Parry
Jennifer F. Iaci
Original Assignee
Acorda Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acorda Therapeutics, Inc. filed Critical Acorda Therapeutics, Inc.
Publication of HK1221666A1 publication Critical patent/HK1221666A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK16109985.0A 2013-04-15 2014-04-14 氨基吡啶用於治疗与某些中风类型相关的视觉障碍的方法 HK1221666A1 (zh)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201361812239P 2013-04-15 2013-04-15
US61/812,239 2013-04-15
US201361816551P 2013-04-26 2013-04-26
US201361816592P 2013-04-26 2013-04-26
US61/816,551 2013-04-26
US61/816,592 2013-04-26
PCT/US2014/033974 WO2014172266A1 (en) 2013-04-15 2014-04-14 Methods for treating sensorimotor impairments associated with certain types of stroke using aminopyridines

Publications (1)

Publication Number Publication Date
HK1221666A1 true HK1221666A1 (zh) 2017-06-09

Family

ID=50841951

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16109985.0A HK1221666A1 (zh) 2013-04-15 2014-04-14 氨基吡啶用於治疗与某些中风类型相关的视觉障碍的方法

Country Status (7)

Country Link
US (1) US20160058743A1 (cg-RX-API-DMAC7.html)
EP (3) EP3243516A1 (cg-RX-API-DMAC7.html)
JP (2) JP2016517856A (cg-RX-API-DMAC7.html)
AU (1) AU2014254164A1 (cg-RX-API-DMAC7.html)
CA (1) CA2909527A1 (cg-RX-API-DMAC7.html)
HK (1) HK1221666A1 (cg-RX-API-DMAC7.html)
WO (1) WO2014172266A1 (cg-RX-API-DMAC7.html)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989009600A1 (en) 1988-04-08 1989-10-19 Massachusetts Institute Of Technology Method and composition for treating neurological disorders
IE82916B1 (en) 1990-11-02 2003-06-11 Elan Corp Plc Formulations and their use in the treatment of neurological diseases
US5952357A (en) 1993-12-23 1999-09-14 Cornell Research Foundation, Inc. Treating diseases of the anterior horn cells
US8007826B2 (en) 2003-12-11 2011-08-30 Acorda Therapeutics, Inc. Sustained release aminopyridine composition
US8354437B2 (en) 2004-04-09 2013-01-15 Acorda Therapeutics, Inc. Method of using sustained release aminopyridine compositions
US20070259960A1 (en) * 2006-02-16 2007-11-08 Fibrogen, Inc. Compounds and methods for treatment of stroke
US20100049236A1 (en) * 2008-08-25 2010-02-25 The Ohio State University Research Foundation Method for testing an agent for strokes in humans with a non-human stroke model
JO3348B1 (ar) * 2009-08-11 2019-03-13 Acorda Therapeutics Inc استخدام 4- بايريدين امينو لتحسين الادراك العصبي و/او التلف النفسي لدى مرضى يعانون من نقص النُخاعين وغير ذلك من امراض الجهاز العصبي
EP2667869A1 (en) * 2011-01-28 2013-12-04 Acorda Therapeutics, Inc. Use of potassium channel blockers to treat cerebral palsy
TWI592156B (zh) * 2011-10-04 2017-07-21 艾可達醫療公司 使用胺基吡啶以治療與中風有關之感覺動作損傷之方法

Also Published As

Publication number Publication date
CA2909527A1 (en) 2014-10-23
US20160058743A1 (en) 2016-03-03
WO2014172266A1 (en) 2014-10-23
AU2014254164A1 (en) 2015-11-05
EP3427735A1 (en) 2019-01-16
EP3243516A1 (en) 2017-11-15
JP2018127497A (ja) 2018-08-16
EP2986292A1 (en) 2016-02-24
JP2016517856A (ja) 2016-06-20

Similar Documents

Publication Publication Date Title
IL267997A (en) Preparations, formulations and methods for treating eye diseases
PH12014501595A1 (en) Substituted annulated pyrimidines and triazines, and use thereof
HK1220980A1 (zh) 用於治疗庞贝氏症的方法和组合物
PH12016500953A1 (en) Tricyclic compounds as anticancer agents
WO2014113089A3 (en) Signal-sensor polynucleotides for the alteration of cellular phenotypes
PH12015501703A1 (en) Trifluormethyl-substituted ring-fused pyrimidines and use thereof
EP3071161A4 (en) Corneal vitrification, methods and devices to produce corneal vitrification and methods of use thereof
MX2015012502A (es) Inhibidores de proteina cinasa dependiente de adn.
PH12014502496B1 (en) Bicyclically substituted uracils and the use thereof
IN2014DN06104A (cg-RX-API-DMAC7.html)
EP3137082A4 (en) Methods to treat, prevent, and improve skin conditions
EP3071214A4 (en) Salacia compositions, methods of treatment by their administration, and methods of their preparation
AU2018253600A1 (en) Dosage forms and therapeutic uses of l-4-chlorokynurenine
MX367393B (es) Composiciones antifungicas para el tratamiento de piel y uñas.
HK1216095A1 (zh) 烟碱乙酰胆碱受体的新的正向别构调节剂
PH12015502564A1 (en) Pyridone derivatives for the treatment of viral infections and further diseases
HK1201204A1 (en) Methods for treating a stroke-related sensorimotor impairment using aminopyridines
HK1211239A1 (en) Treatment regimens
WO2014140856A3 (en) Mir-142 and antagonists thereof for treating disease
WO2013163562A3 (en) Compositions and methods for treating ptsd and related diseases
AU2012240388A8 (en) Treatment regimens
WO2013057554A3 (en) Therapeutic combinations of netupitant and palonosetron
NZ629475A (en) Pharmaceutical composition comprising benzyl alcohol for the treatment of migraines
WO2012119045A3 (en) Compositions and uses thereof to ameliorate pain
PH12014000104A1 (en) Therapeutic methods and compositions for treating diabetes